Ahmed Zayed Obeidat, MD, PhD
Associate Professor
Locations
- Froedtert Hospital
- Neuroscience Center – Specialty Clinics
Specialties
- Neurology
Languages
- English, Arabic
New & Established Patients Call
Education
- MD - Doctor of Medicine
- PhD
Research Experience
- Adult
- Female
- Humans
- Incidence
- Infant, Newborn
- Jordan
- Male
- Multiple Sclerosis
- Neural Tube Defects
Clinical Expertise
- Adult
- Female
- Humans
- Incidence
- Infant, Newborn
- Jordan
- Male
- Multiple Sclerosis
- Neural Tube Defects
- Neuromyelitis Optica
Methodologies and Techniques
- Adult
- Electrophysiology
- Humans
- Incidence
- Infant, Newborn
- Jordan
- Male
- Motor Neurons
- Neural Tube Defects
- Renshaw Cells
- Synapses
Leadership Positions
- A Nominated Member of Wright State University for the American Association for theAdvancement of Science/ Program for Excellence in Science, 2011 – Present.
- Appointed to the Board of Directors of Global Music and Wellness (a non-profit organization based in Cincinnati, OH) – current term: January 2018 - January2021
- Chair, Graduate Student Assembly Research Symposium Organizing Committee, 2012.
- Co-Chair - the Consortium of Multiple Sclerosis Centers MS Professionals-in-Training Special Interest Group (MS-PiT), (2016 – Present)
- Co-Chair of “Presidential Search Committee”. Society for Arab Neuroscientists (2016)
- Elected by Wright State University for membership in The Phi Kappa Phi HonorSociety: Top 10% in each Graduate program, 2010 – Present.
- Elected to represent Jordan University of Science & Technology in the 24th PlenarySession of the Interaction Council, under the patronage of King Abdullah II. Dead Sea, Jordan, 5/2006.
- Elected to represent Jordan University of Science and Technology in the “East-WestInitiative,” student leadership forum, held at the Marriott Hotel Amman, Jordan, 6/2008.
- Elected to serve as the “Secretary” for the First International Brain Research Organization(IBRO) – United Arab Emirates neuroscience school, Al Ain, UAE, 1/2007.
- International Online Medical Conference Abstract Review Committee, 2008, 2009.
- Invited to serve as the discussion leader for the session of “Interneurons in Health andDisease” during the “Inhibition in the CNS” Gordon Research Conference, Lewiston,ME, 8/2015.
- Member of Student Board Committee of the 1st and 2nd International OnlineMedical Conference (2008, 2009).
Educational Expertise
- Humans
- Incidence
- Jordan
- Multiple Sclerosis
- Neural Tube Defects
- Neuromyelitis Optica
Publications
-
Clinical decision support improves autoimmune/paraneoplastic antibody panel utilization.
(Nerenz RD, Hooshmand SI, Jackowiak E, Shirilla D, Yang Y, Yang K, Obeidat AZ.) Am J Clin Pathol. 2024 Sep 10 PMID: 39255415 09/10/2024
-
JC virus or extended interval dosing? More data are needed.
(Obeidat AZ.) Mult Scler. 2024 Sep 06:13524585241272975 PMID: 39240139 SCOPUS ID: 2-s2.0-85203433093 09/06/2024
-
(Porwal MH, Razzak AN, Kumar V, Obeidat AZ, Sharma U.) Epilepsy Res. 2024 Jul;203:107382 PMID: 38761467 SCOPUS ID: 2-s2.0-85193210316 05/19/2024
-
Impact of neuromyelitis optica spectrum disorder on employment and income in the United States.
(Hjerthen IG, Trápaga Hacker C, Meador W, Obeidat AZ, Horta L, Mateen FJ.) Ann Clin Transl Neurol. 2024 Apr;11(4):1011-1020 PMID: 38374778 PMCID: PMC11021617 SCOPUS ID: 2-s2.0-85186173891 02/20/2024
-
Progressive multifocal leukoencephalopathy in patients with chronic kidney disease.
(Meylor J, Artunduaga DC, Mendoza M, Hooshmand SI, Obeidat AZ.) Neurol Sci. 2024 Apr;45(4):1619-1624 PMID: 37950135 SCOPUS ID: 2-s2.0-85176588688 11/11/2023
-
Identification and management of subclinical disease activity in early multiple sclerosis: a review.
(Ontaneda D, Chitnis T, Rammohan K, Obeidat AZ.) J Neurol. 2024 Apr;271(4):1497-1514 PMID: 37864717 PMCID: PMC10972995 SCOPUS ID: 2-s2.0-85174576757 10/21/2023
-
Increased healthcare utilization in the year before multiple sclerosis diagnosis.
(Razzak AN, Hernandez RS, Salter A, Obeidat AZ.) Mult Scler Relat Disord. 2024 Mar;83:105438 PMID: 38242052 SCOPUS ID: 2-s2.0-85183017643 01/20/2024
-
A closer look at reported colitis in association with multiple sclerosis treatments.
(Porwal MH, Obeidat AZ.) Mult Scler. 2024 Mar;30(3):453-455 PMID: 37897260 SCOPUS ID: 2-s2.0-85175354253 10/29/2023
-
Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
(Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, Kalbus O, Staikov I, Dufek M, Saubadu S, Bejuit R, Truffinet P, Djukic B, Wallstroem E, Giovannoni G, Frexalimab Phase 2 Trial Group.) N Engl J Med. 2024 Feb 15;390(7):589-600 PMID: 38354138 02/14/2024
-
(Obeidat AZ.) Mult Scler Relat Disord. 2024 Feb;82:105389 PMID: 38118288 SCOPUS ID: 2-s2.0-85180351134 12/21/2023
-
(Palathinkara M, Razzak AN, Ababneh OE, Cairns D, Obeidat AZ.) Mult Scler Relat Disord. 2023 Dec;80:105132 PMID: 37951095 SCOPUS ID: 2-s2.0-85176602731 11/12/2023
-
Molecular biomarkers and cognitive impairment in multiple sclerosis: A review
(Esmaeili S, Obeidat AZ, Zabeti A.) Biomarkers in Neuropsychiatry. December 2023;9 SCOPUS ID: 2-s2.0-85173250674 12/01/2023